Health Condition 1: G560- Carpal tunnel syndrome
Conditions
Interventions
Intervention1: Hydrodissection using 5%dextrose: Median nerve will be identified using USG.
5cc to 10 cc of 5% dextrose (depending upon the completeness of the laminar separation) will be slowly inje
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients having NCS proven carpal tunnel syndrome with persistent symptoms not resolving after 6-8 weeks of medications or splinting referred from orthopaedics department for hydrodissection
Exclusion criteria
Exclusion criteria: : Patients with other neurological causes like polyneuropathies, thoracic outlet syndrome, cervical radiculopathy; secondary causes like ganglion cysts, accessory muscles; received prior steroid injection / carpal tunnel release surgery ; thenar atrophy; local site infection , history of Colles’ fracture; uncontrolled diabetes / diabetic neuropathy , uncontrolled hypothyroidism or bleeding diathesis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of improvement in BCTQ(SSS), BCTQ (FSS), VAS and CSA of median nerve from pre procedure to post procedure in both groups.Timepoint: At 1 month , 3 month and wherever possible 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Change from baseline of BCTQ (SSS), BCTQ (FSS) and VAS after ultrasound guided hydrodissection with 5% dextrose . 2. Change from baseline of BCTQ (SSS), BCTQ (FSS) and VAS after ultrasound guided hydrodissection with normal saline . 3. Change from baseline of cross-sectional area (CSA) of the median nerve using ultrasound in both groups. 4. Comparison of complications between the two injectate groups (expressed as %). Timepoint: At 1 month , 3 month and wherever possible 6 months | — |
Countries
India
Contacts
Public ContactDr Anupama Tandon
Department of Radiodiagnosis, UCMS and GTB Hospital, Dilshad Garden, Delhi
Outcome results
None listed